Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors is a research paper published in JNCI Journal of the National Cancer Institute (2024). On theSindex it has a DataRank of 0. It has been cited 51 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: HHSN 261201800469P
National Cancer Institute
Grant: HHSN 261201700708P
National Cancer Institute
Grant: HHSN 261201600711P
National Cancer Institute
Grant: HHSN 26120090017C
National Cancer Institute
Grant: 6648-00-S010
NIH
Grant: 1R01CA1205621
NIH
Grant: P01CA154292
Fred Hutchinson Cancer Research Center
Grant: N01-CN-67009
Fred Hutchinson Cancer Research Center
Grant: N01-PC-35142
National Cancer Institute
Grant: R50CA211115
NCI NIH HHS
Grant: N01 PC035142
Kaiser Permanente Washington
Surveillance, Epidemiology and End Results
State of Washington
Fred Hutchinson Cancer Research Center
Cancer Surveillance System
FWCI
15.10
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals